Literature DB >> 32239013

A nano-based thermotherapy for cancer stem cell-targeted therapy.

Xiaomin Suo1, Juncai Zhang1, Yue Zhang1, Xing-Jie Liang2, Jinchao Zhang1, Dandan Liu1.   

Abstract

Cancer stem cells (CSCs) exhibit high resistance to conventional therapy and are responsible for cancer metastasis and tumor relapse. Therefore, it is of significance to develop effective novel strategies to target CSCs for cancer therapies. The challenges associated with developing novel strategies include specific CSC targeting and overcoming their therapeutic resistance. In the present review, we summarize the various strategies for CSC-targeted cancer thermotherapy and combinational therapy, and the potential challenges and prospects for future work in this emerging field.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32239013     DOI: 10.1039/d0tb00311e

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  5 in total

Review 1.  Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges.

Authors:  Francisco Rodríguez; Pablo Caruana; Noa De la Fuente; Pía Español; María Gámez; Josep Balart; Elisa Llurba; Ramón Rovira; Raúl Ruiz; Cristina Martín-Lorente; José Luis Corchero; María Virtudes Céspedes
Journal:  Biomolecules       Date:  2022-06-04

Review 2.  Nanotechnology-based combinatorial phototherapy for enhanced cancer treatment.

Authors:  Han Chen; Peter Timashev; Yuanyuan Zhang; Xiangdong Xue; Xing-Jie Liang
Journal:  RSC Adv       Date:  2022-04-04       Impact factor: 3.361

Review 3.  Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting.

Authors:  Shweta Bisht; Manisha Nigam; Shyam S Kunjwal; Plygun Sergey; Abhay Prakash Mishra; Javad Sharifi-Rad
Journal:  Stem Cells Int       Date:  2022-06-28       Impact factor: 5.131

4.  Synthesis of manganese-oxide and palladium nanoparticles co-decorated polypyrrole/graphene oxide (MnO2@Pd@PPy/GO) nanocomposites for anti-cancer treatment.

Authors:  Jiarui Wu; Meng Wang; Yuanjie Pan; Yipeng Pang; Yanyan Tang; Chang Song; Jiahui Zhu; Xian Zhang; Qingli Huang
Journal:  RSC Adv       Date:  2022-08-22       Impact factor: 4.036

5.  Juxtamembrane 2 mimic peptide competitively inhibits mitochondrial trafficking and activates ROS-mediated apoptosis pathway to exert anti-tumor effects.

Authors:  Dan He; Zhijie Ma; Ke Xue; Haiyan Li
Journal:  Cell Death Dis       Date:  2022-03-24       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.